Serina Therapeutics Stock Alpha and Beta Analysis
| SER Stock | 4.79 0.64 15.42% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Serina Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Serina Therapeutics over a specified time horizon. Remember, high Serina Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Serina Therapeutics' market risk premium analysis include:
Beta (0.87) | Alpha (0.10) | Risk 7.92 | Sharpe Ratio (0.01) | Expected Return (0.06) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Serina |
Serina Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Serina Therapeutics market risk premium is the additional return an investor will receive from holding Serina Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Serina Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Serina Therapeutics' performance over market.| α | -0.1 | β | -0.87 |
Serina Therapeutics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Serina Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how Serina Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Serina Therapeutics Market Price Analysis
Market price analysis indicators help investors to evaluate how Serina Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Serina Therapeutics shares will generate the highest return on investment. By understating and applying Serina Therapeutics stock market price indicators, traders can identify Serina Therapeutics position entry and exit signals to maximize returns.
Serina Therapeutics Return and Market Media
The median price of Serina Therapeutics for the period between Thu, Sep 19, 2024 and Wed, Dec 18, 2024 is 6.34 with a coefficient of variation of 18.22. The daily time series for the period is distributed with a sample standard deviation of 1.11, arithmetic mean of 6.1, and mean deviation of 0.99. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Employers Have A Responsibility To Address Age Stereotypes | 09/27/2024 |
2 | Bidens top aides denied he was disintegrating asdonors warned prezs aging appearance was f--king up campaign book | 10/10/2024 |
3 | Acquisition by Harris J Milton of 40000 shares of Serina Therapeutics at 11.828 subject to Rule 16b-3 | 10/14/2024 |
4 | Market Highlights McDonalds, Starbucks slump as gold nears 2,750 ASX to open higher | 10/22/2024 |
5 | Tom Hanks, 68, reveals the surprising age he absolutely hated Your bones start wearing off | 11/01/2024 |
6 | Serina Therapeutics Inc trading resumes - TipRanks | 11/07/2024 |
7 | Acquisition by Mintz Steven of 5000 shares of Serina Therapeutics at 9.5 subject to Rule 16b-3 | 11/11/2024 |
8 | Acquisition by Bailey Gregory of 1776 shares of Serina Therapeutics at 8.25 subject to Rule 16b-3 | 11/15/2024 |
9 | Worlds oldest man, John Tinniswood, dies at 112 | 11/26/2024 |
10 | ALPHA AESTHETICS PARTNERS ANNOUNCES STRATEGIC PARTNERSHIP WITH CAROLINA AGE MANAGEMENT INSTITUTE , LED BY DR. STEPHEN GIORDANO | 12/03/2024 |
11 | Jennifer Lopez interviewer awkwardly calls out her age Did he just say that | 12/17/2024 |
About Serina Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Serina or other stocks. Alpha measures the amount that position in Serina Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Graham Number | 29.34 | 44.26 | 39.55 | 44.83 | Receivables Turnover | 2.7K | 2.49 | 2.24 | 2.13 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Serina Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Serina Therapeutics' short interest history, or implied volatility extrapolated from Serina Therapeutics options trading.
Build Portfolio with Serina Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Serina Stock Analysis
When running Serina Therapeutics' price analysis, check to measure Serina Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Serina Therapeutics is operating at the current time. Most of Serina Therapeutics' value examination focuses on studying past and present price action to predict the probability of Serina Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Serina Therapeutics' price. Additionally, you may evaluate how the addition of Serina Therapeutics to your portfolios can decrease your overall portfolio volatility.